A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.-论文-万方医学网

作者： Shan-Shan,Jiang ^[1] ; Yan,Tang ^[1] ; Yao-Jun,Zhang ^[2] ; D-Sheng,Weng ^[1] ; Zhong-Guo,Zhou ^[2] ; Ke,Pan ^[1] ; Qiu-Zhong,Pan ^[1] ; Qi-Jing,Wang ^[1] ; Qing,Liu ^[1] ; Jia,He ^[1] ; Jing-Jing,Zhao ^[1] ; Jiang,Li ^[1] ; Min-Shan,Chen ^[2] ; Alfred E,Chang ^[3] ; Qiao,Li ^[3] ; Jian-Chuan,Xia ^[1]

作者单位： Department of Biotherapy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. ^[1] Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[2] University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. ^[3]

主题词成年人(Adult);老年人(Aged);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌, 肝细胞(Carcinoma, Hepatocellular);细胞因子类(Cytokines);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);白细胞减少(Leukopenia);肝肿瘤(Liver Neoplasms);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);中性粒细胞减少(Neutropenia);存活率(Survival Rate);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)

DOI 10.18632/oncotarget.5463

PMID 26515587

发布时间 2018-11-13

检索历史清除

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Oncotarget

相似文献

Oncotarget

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.

Oncotarget

相似文献

Oncotarget

相关期刊

检索历史清除